Literature DB >> 29999209

Congenital-type juvenile xanthogranuloma: A case series and literature review.

Vikash S Oza1, Thomas Stringer2, Caren Campbell3, Brian Hinds4, Sarah L Chamlin5, Ilona J Frieden2, Sonal Shah2.   

Abstract

BACKGROUND/
OBJECTIVES: Congenital juvenile xanthogranulomas are infrequently described in the medical literature. We report three previously unpublished cases and systematically review the literature to better characterize this variant.
METHODS: We surveyed English-language articles indexed in MEDLINE (1951-March 2017) and EMBASE (1974-March 2017) for cases of congenital-onset juvenile xanthogranulomas confirmed on histopathology. Cases were divided into two categories: cutaneous only or cutaneous with systemic involvement.
RESULTS: We identified 31 cases of congenital juvenile xanthogranulomas involving only the skin and 16 cases with systemic involvement. Congenital juvenile xanthogranulomas involving only the skin were large (> 3 cm), presented with various clinical morphologies, and showed signs of regression by 1 year of age. Atypical clinical presentations included exophytic tumors, infiltrative plaques, agminated plaques, and subcutaneous tumors. Complications included ulceration and anetodermic scarring. Infants with congenital cutaneous juvenile xanthogranulomas who also had systemic involvement typically had multiple cutaneous tumors and hepatic involvement and showed signs of spontaneous regression independent of treatment.
CONCLUSIONS: The medical literature supports that congenital juvenile xanthogranulomas behave in a fashion similar to that of juvenile xanthogranulomas of infancy or childhood. Congenital cutaneous juvenile xanthogranulomas with or without systemic involvement spontaneously regress. The varied clinical presentations in the skin may lead to misdiagnosis, inappropriate examination, and unnecessary treatments. Infants with multiple congenital cutaneous juvenile xanthogranulomas should be evaluated for systemic involvement, with a particular focus on the liver, because 72.2% of these children were found to have hepatic juvenile xanthogranulomas.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital juvenile xanthogranuloma; juvenile xanthogranuloma; systemic juvenile xanthogranuloma

Mesh:

Year:  2018        PMID: 29999209     DOI: 10.1111/pde.13544

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  5 in total

1.  Neonatal systemic juvenile Xanthogranuloma with Hydrops diagnosed by Purpura skin biopsy: a case report and literature review.

Authors:  Yohji Uehara; Yuka Sano Wada; Yuka Iwasaki; Kota Yoneda; Yasuhisa Ikuta; Shoichiro Amari; Hidehiko Maruyama; Keiko Tsukamoto; Tetsuya Isayama; Kenichi Sakamoto; Yoko Shioda; Osamu Miyazaki; Rie Irie; Takako Yoshioka; Naoko Mochimaru; Kazue Yoshida; Yushi Ito
Journal:  BMC Pediatr       Date:  2021-04-06       Impact factor: 2.125

2.  Juvenile Xanthogranuloma as Differential Diagnosis of a Vulvar Mass: A Case Report.

Authors:  Isabel Bada Bosch; Agustín Del Cañizo; Minia Campos-Domínguez; Javier Ordoñez; María Dolores Blanco Verdú; María Fanjul; Laura Pérez-Egido; Juan Carlos de Agustín
Journal:  European J Pediatr Surg Rep       Date:  2022-04-19

Review 3.  The various clinical spectra of juvenile xanthogranuloma: imaging for two case reports and review of the literature.

Authors:  Michaela Höck; Bernhard Zelger; Gisela Schweigmann; Barbara Brunner; Bettina Zelger; Gabriele Kropshofer; Ursula Kiechl-Kohlendorfer
Journal:  BMC Pediatr       Date:  2019-04-24       Impact factor: 2.125

4.  Firm, enlarging papule on an infant's proximal thigh.

Authors:  Cynthia Ytram Truong; Alex Nguyen; Tara Braun; Aurdrey Chan
Journal:  JAAD Case Rep       Date:  2021-11-10

5.  Successful Treatment of Non-Langerhans Cell Histiocytosis With Topical Rapamycin in Two Pediatric Cases.

Authors:  Raden Mohamad Rendy Ariezal Effendi; Trustia Rizqandaru; Renata Yuliasari; Srie Prihianti Gondokaryono; Inne Arline Diana; Reiva Farah Dwiyana
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.